• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Fresenius’ renal research division gets a makeover

Fresenius’ renal research division gets a makeover

March 26, 2014 By Arezu Sarvestani

Fresenius forms renal research arm

Dialysis giant Fresenius (NYSE:FMS) re-introduced its renal research branch, renaming it "Frenova" and reiterating the group’s commitment to developing novel therapies.

Frenova, formerly known as the "Clinical Studies Group at FMCNA," has been around since 2001 and provides support for clinical trials specific to kidney disease and related conditions. Frenova is the only Phase I-V clinical partner dedicated to medical device and drug research for renal therapies, Fresenius noted.

"Frenova is a new name, but the company is built on more than a decade of experience focused exclusively on the clinical development of new renal therapies largely developed using the world’s largest dialysis treatment and research network," Frenova vice president and general manager Kurt Mussina said in prepared remarks. "Developing treatments to improve the quality of life for people with kidney disease has always been our singular objective. Our new identity as Frenova reflects that mission and will play a key role in furthering it."

The R&D group provides partners with data on more than 390,000 pre-dialysis patients with chronic kidney disease as well as 183,000 end stage renal disease patients undergoing dialysis. Frenova also holds significant clinical data from 2 decades’ worth of real-world clinical trials, the company said.

The re-branding announcement comes amid some tough time for Fresenius, which faces a difficult year ahead after dealing with inspection issues and reimbursement pressure from regulators

FMS shares were up 0.4% today, trading at $34.73 as of about 2:55 p.m. The stock is down 2.5% since the start of the year.

Filed Under: News Well, Research & Development Tagged With: Clinical Trials, Dialysis, Frenova, Fresenius, Innovation

More recent news

  • Mount Sinai adopts Flosonics wearable ultrasound device
  • GE HealthCare launches next-gen intraoperative ultrasound
  • Philips launches new point-of-care ultrasound system
  • Medtronic to invest $50M in India Diabetes center
  • Corvia Medical raises $55M as it seeks FDA nod for atrial shunt

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy